FXN and Friedreich ataxia: In alignment with the in vivo results presented by Kilikevicius et al., our in vitro findings in FRDA patient-derived cell lines confirm that the same ASO sequence (CTT) utilized in their animal model leads to downregulation of FXN expression in our cell models as well.38